A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy.
about
Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.Cardiotoxicity with vascular endothelial growth factor inhibitor therapyStatistical considerations in reporting cardiovascular research
P2860
A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A novel complex I inhibitor pr ...... left ventricular hypertrophy.
@en
type
label
A novel complex I inhibitor pr ...... left ventricular hypertrophy.
@en
prefLabel
A novel complex I inhibitor pr ...... left ventricular hypertrophy.
@en
P2093
P2860
P1476
A novel complex I inhibitor pr ...... left ventricular hypertrophy.
@en
P2093
Carrie-Lynn M Soltys
Donna L Beker
Grant Masson
Ian M Robertson
Jason R B Dyck
Miranda M Sung
Nobutoshi Matsumura
Shereen M Hamza
P2860
P304
P356
10.1152/AJPHEART.00604.2016
P577
2017-01-06T00:00:00Z